Sidley Life Sciences Briefing
Through the Looking Glass: What WHA79 Reveals About the Future of Global Life Sciences
August 2026
Authors
World Health Assembly 79 offered valuable insights into the policy landscape facing pharmaceutical, biotechnology, medtech, and digital health companies worldwide, with four themes emerging most clearly: increasing reliance on data-driven healthcare, growing expectations regarding equitable access, continued focus on antimicrobial resistance and pandemic preparedness, and heightened attention to governance of emerging technologies.
Offices
Related Blogs
Capabilities
Suggested News & Insights
Sidley Advises HJ Science on Its Successful Chapter 18A Listing in Hong KongJune 23, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026EU Pharma Package: Compromise Text Published – Best Efforts Required (Part 2)May 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory